Profound Medical (PROF) Gains from Sales and Divestitures (2023 - 2026)
Profound Medical (PROF) recorded quarterly Gains from Sales and Divestitures of $10000.0 in Q1 2026, down 94.17% quarter-over-quarter from $171618.0 in Q4 2025, and down 25.0% on a YoY basis from $13333.0 in Q1 2025.
Profound Medical (PROF) Gains from Sales and Divestitures (2023 - 2026) Analysis & Trends
Profound Medical's Gains from Sales and Divestitures history runs 4 years deep, the most recent figure standing at $10000.0 for Q1 2026.
- In Q1 2026, Gains from Sales and Divestitures fell 25.0% year-over-year to $10000.0; the TTM figure through Mar 2026 stood at $10000.0 (down 25.0% YoY), while the FY2025 annual figure was $171618.0, up 1960.24% from the prior year.
- Gains from Sales and Divestitures was $10000.0 for Q1 2026 at Profound Medical, down from $171618.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $171618.0 in Q4 2025 to a low of $8330.0 in Q4 2024.
- Historically, Gains from Sales and Divestitures has averaged $33564.1 across 4 years, with a median of $10000.0 in 2023.
- The sharpest annual moves came in 2025 and 2026: Gains from Sales and Divestitures jumped 1960.24% in 2025, then slipped 25.0% in 2026.
- A 4-year view of Gains from Sales and Divestitures shows it stood at $10000.0 in 2023, then slipped by 16.7% to $8330.0 in 2024, then surged by 1960.24% to $171618.0 in 2025, then plunged by 94.17% to $10000.0 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $10000.0 (Q1 2026), $171618.0 (Q4 2025), and $8335.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Profound Medical | 240.29 Mn | 190.00 Mn | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | 171,618.00 |
| Dec 31, 2025 | 171,618.00 |
| Sep 30, 2025 | 8,335.00 |
| Sep 30, 2025 | 8,335.00 |
| Jun 30, 2025 | 13,333.00 |
| Jun 30, 2025 | 13,333.00 |
| Mar 31, 2025 | 13,333.00 |
| Mar 31, 2025 | 13,333.00 |
| Dec 31, 2024 | 8,330.00 |
| Dec 31, 2024 | 8,330.00 |
| Dec 31, 2023 | 10,000.00 |
| Dec 31, 2023 | 10,000.00 |